Atux Iskay Group
UEI: C7JPQ5F3UUH7
• CAGE: 88C46
Overview
Awardee Type
Parent
Federal Capability Statement
Small molecule medicinal chemistry and Organic Synthesis. Proprietary PP2A activator therapeutics. Reagents for PP2A assay development
Keywords
Medicinal Chemistry, Organic Synthesis, Therapeutics, Drug Discovery, Anti-cancer drugs, Anti-inflammatory drugs, Alzheimer's treatment
SBA Special Equipment
Proprietary PP2A activator compounds. Reagents for assay development
Headquarters
Plainsboro, NJ
United States
United States
Most Recent Award
Feb. 15, 2024
Calculating
Federal contract and grant recipient
ATUX ISKAY GROUP LLC
(UEI C7JPQ5F3UUH7, CAGE 88C46)
is headquartered in Plainsboro NJ.
Its primary registered NAICS is 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
The corporation
was founded in May 2017 and
federally registered in
January 2019.
Federal Award Analysis
Atux Iskay Group federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
ATUX ISKAY GROUP LLC
UEI
C7JPQ5F3UUH7
CAGE Code
88C46
Primary NAICS
SBA Certifications
None
Self Certifications
For Profit Organization, Limited Liability Company
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
May 11, 2017
Initial Registration
Jan. 14, 2019
Last Registration
Jan. 9, 2026
Registration Activation
Jan. 9, 2026
Registration Expiration
Jan. 6, 2027
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
Limited Liability Company
Limited Liability Company
State of Incorporation
NJ
Country of Incorporation
USA
Employees
<500
Reported NAICS
Accepts Credit Cards
No